Important Safety Information for Lantus®
Contraindications
Lantus® is contraindicated in patients hypersensitive to insulin glargine or one
of its excipients.
Warnings and precautions
Monitor blood glucose in all patients treated with insulin. Insulin regimens should
be modified cautiously and only under medical supervision. Changes in insulin strength,
manufacturer, type, or method of administration may result in the need for a change
in insulin dose or an adjustment in concomitant oral antidiabetic treatment.
Do not dilute or mix Lantus® with any other insulin or solution. If mixed or diluted,
the solution may become cloudy, and the onset of action/time to peak effect may
be altered in an unpredictable manner. Do not administer Lantus® via an insulin
pump or intravenously because severe hypoglycemia can occur. Insulin devices and
needles must not be shared between patients.
Hypoglycemia is the most common adverse reaction of insulin therapy, including Lantus®,
and may be life-threatening.
Severe life-threatening, generalized allergy, including anaphylaxis, can occur.
A reduction in the Lantus® dose may be required in patients with renal or hepatic
impairment.
Drug interactions
Certain drugs may affect glucose metabolism, requiring insulin dose adjustment and
close monitoring of blood glucose. The signs of hypoglycemia may be reduced in patients
taking anti-adrenergic drugs (e.g., beta-blockers, clonidine, guanethidine, and
reserpine).
Adverse reactions
Other adverse reactions commonly associated with Lantus® are injection site reaction,
lipodystrophy, pruritus, and rash.
Important Safety Information for Lantus® SoloSTAR®
Lantus® SoloSTAR® is a disposable prefilled insulin pen. To help ensure an accurate
dose each time, patients should follow all steps in the Instruction Leaflet accompanying
the pen; otherwise they may not get the correct amount of insulin, which may affect
their blood glucose.
Indications and Usage for Lantus®
Lantus® is a long-acting insulin analog indicated to improve glycemic control in
adults and children (6 years and older) with type 1 diabetes mellitus and in adults
with type 2 diabetes mellitus. Lantus® should be administered once a day at the
same time every day.
Important Limitations of Use: Lantus® is not recommended for the treatment of diabetic
ketoacidosis. Use intravenous short-acting insulin instead.
Please click here for full prescribing information